What is the address of DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE?

The registered office of DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE is located at Kerkweg 13, 2830 Willebroek.

Is DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE still active?

Yes. According to the CBE (18 September 2026) DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE is active, legal situation “Normale toestand”, started on 13 July 2022.

Is DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE registered on Peppol?

Yes, DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE is registered on the Peppol network with ID 0208:0788535368.

What is the enterprise number of DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE?

The enterprise number of DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE is BE0788535368.

When was DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE founded?

DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE was founded on 13 July 2022.

Who are the directors of DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE?

According to the 2025 annual accounts, the directors of DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE are: Olivier Cuche, Heleen-Elise Pardon.

Is DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 July 2022; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE make in 2025?

DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE posted a profit after taxes of € 111,782 in financial year 2025.

What is the revenue of DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE?

As a small company, DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 155,546.

DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE (Private Limited)

Dossier DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE, printed on 18 September 2026 from databakkes.be/en/0788535368/dr-cuche-cardiologie-dr-pardon-chirurgie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE from Willebroek, company number BE0788535368, closed financial year 2025 with a result of € 111,782 after tax. For that financial year DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE recorded a gross margin of € 155,546 and equity of € 84,282. Compared with financial year 2024, the result moved from € 126,375 to € 111,782. The company is profitable. The buffer shrank hard: equity is 71 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.

What it is worth Shrank hard

€ 84,282

▼ 71% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 111,782

▼ 12% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 306,962

▲ 49% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 317,193 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 15,207

▼ 39% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,249

▼ 41% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 11,099

▲ 12% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 64,963 Gross margin 2022: € 64,963 First fiscal year in the series	€ 137,421 Gross margin 2023: € 137,421 ▲ 112% vs 2022 (€ 64,963) Favourable step	€ 169,784 Gross margin 2024: € 169,784 ▲ 24% vs 2023 (€ 137,421) Favourable step	€ 155,546 Gross margin 2025: € 155,546 ▼ 8% vs 2024 (€ 169,784) Unfavourable step	▼ 8%
Profit after taxes	€ 49,253 Profit after taxes 2022: € 49,253 First fiscal year in the series	€ 106,564 Profit after taxes 2023: € 106,564 ▲ 116% vs 2022 (€ 49,253) Favourable step	€ 126,375 Profit after taxes 2024: € 126,375 ▲ 19% vs 2023 (€ 106,564) Favourable step	€ 111,782 Profit after taxes 2025: € 111,782 ▼ 12% vs 2024 (€ 126,375) Unfavourable step	▼ 12%
Equity	€ 56,753 Equity 2022: € 56,753 First fiscal year in the series	€ 163,317 Equity 2023: € 163,317 ▲ 188% vs 2022 (€ 56,753) Favourable step	€ 289,693 Equity 2024: € 289,693 ▲ 77% vs 2023 (€ 163,317) Favourable step	€ 84,282 Equity 2025: € 84,282 ▼ 71% vs 2024 (€ 289,693) Unfavourable step	▼ 71%
Total debts	€ 7,648 Total debts 2022: € 7,648 First fiscal year in the series	€ 21,761 Total debts 2023: € 21,761 ▲ 185% vs 2022 (€ 7,648) Unfavourable step	€ 13,133 Total debts 2024: € 13,133 ▼ 40% vs 2023 (€ 21,761) Favourable step	€ 331,681 Total debts 2025: € 331,681 ▲ € 318,548 vs 2024 (€ 13,133) Unfavourable step	▲ € 318,548
Cash	€ 16,334 Cash 2022: € 16,334 First fiscal year in the series	€ 109,772 Cash 2023: € 109,772 ▲ € 93,438 vs 2022 (€ 16,334) Favourable step	€ 205,833 Cash 2024: € 205,833 ▲ 88% vs 2023 (€ 109,772) Favourable step	€ 306,962 Cash 2025: € 306,962 ▲ 49% vs 2024 (€ 205,833) Favourable step	▲ 49%
Retained profit	€ 49,253 Retained profit 2022: € 49,253 First fiscal year in the series	€ 155,817 Retained profit 2023: € 155,817 ▲ 216% vs 2022 (€ 49,253) Favourable step	€ 282,193 Retained profit 2024: € 282,193 ▲ 81% vs 2023 (€ 155,817) Favourable step	€ 76,782 Retained profit 2025: € 76,782 ▼ 73% vs 2024 (€ 282,193) Unfavourable step	▼ 73%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 317,193 Dividend 2025: € 317,193 Unchanged (€ 0) Unchanged
Balance sheet total	€ 64,401 Balance sheet total 2022: € 64,401 First fiscal year in the series	€ 185,078 Balance sheet total 2023: € 185,078 ▲ 187% vs 2022 (€ 64,401) Unchanged	€ 302,825 Balance sheet total 2024: € 302,825 ▲ 64% vs 2023 (€ 185,078) Unchanged	€ 415,963 Balance sheet total 2025: € 415,963 ▲ 37% vs 2024 (€ 302,825) Unchanged	▲ 37%

Key figures of DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE?

What happened at DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 6, 2026 New annual accounts for financial year 2025: profit of € 111,782 (▼ 12% vs 2024). Source: NBB ↗
2024 Heleen-Elise Pardon became a director. NBB
Jul 13, 2022 New establishment in Willebroek. KBO
2022 Olivier Cuche became a director. NBB
Jul 13, 2022 Start of the company according to the CBE. KBO

In short

From € 49,253 profit in 2022 to € 111,782 profit in 2025.

Paid € 112,736 in corporate taxes since 2022.

Best year ever: 2024, with € 126,375 profit.

Paid out € 317,193 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE? We notify you, reason included.

Follow DR. CUCHE, CARDIOLOGIE & DR. PARDON, CHIRURGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit